Article

Bausch & Lomb appoints new CEO

Bausch & Lomb announced it has appointed Gerald M. Ostrov as chairman and chief executive officer to succeed Ronald Zarella.

Rochester, NY

-Bausch & Lomb announced it has appointed Gerald M. Ostrov as chairman and chief executive officer to succeed Ronald Zarella.

Ostrov, 58, most recently was company group chairman, worldwide vision care, for Johnson & Johnson from 1998 to 2006. He first joined Johnson & Johnson in 1976, before leaving for Ciba-Geigy AG in 1982. He returned to Johnson & Johnson in 1991.

Zarella, also 58, took over at Bausch & Lomb in 2001 and will retire in March but will stay on as chairman emeritus. He previously served as chairman and president of General Motors Corp.

"It's an honor to lead Bausch & Lomb into a growth period, one that we believe will be marked by considerable success across the vision care, pharmaceutical and surgical businesses," Ostrov said in a prepared statement.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.